Stage I Gastric Cancer Clinical Trial
Official title:
A Study Evaluating Effect of Smart Phone App-based Human Coaching Program on QOL in Patients Who Underwent Gastrectomy for Stage I Gastric Cancer
NCT number | NCT04394585 |
Other study ID # | 1910242 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | April 20, 2020 |
Est. completion date | December 2023 |
This study is a single center, prospective, randomized controlled study. The aim of this study is to evaluate the effect of smart phone app-based human coaching program on QOL in patients who underwent gastrectomy for stage I gastric cancer. The hypothesis of this study is the patients who used smart phone app-based human coaching program for three months after surgery will have better QOL than patients who did not use it. The QOL will be assessed using EORTC QLQ C30 and STO22 at 3 months postoperatively. The secondary endpoints are QOL at 6 months postoperatively, 12 months postoperative, food intake, body composition, and nutritional indicators from blood test.
Status | Recruiting |
Enrollment | 180 |
Est. completion date | December 2023 |
Est. primary completion date | November 2, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years and older |
Eligibility | Inclusion Criteria: - patient aged 19 or more - patient diagnosed as stage I in preoperative examination - planned distal gastrectomy or total gastrectomy - patient who can use smart phone app or whose family can help the - patient to use the smart phone app Exclusion Criteria: - pregnant - disabled to communication - patient who cannot use smart phone app |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Bang Wool Eom | Goyang | Gyeonggi-do |
Lead Sponsor | Collaborator |
---|---|
National Cancer Center, Korea |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Eating restriction score (XEatR) at 3 months postoperatively | Eating resection scale is calcuated according to the following equation.
Add questionnaire items 41,42, 43 and 46 and divide this sum by the number of items (4): EatR = (Q41+Q42+Q43+Q46)/4 Carry out a linear transformation to convert to a 1-100 scale: XEatR = (EatR-1)*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life. |
3 months postoperatively | |
Secondary | Eating restriction score (XEatR) at 6 months postoperatively | Eating resection scale is calcuated according to the following equation.
Add questionnaire items 41,42, 43 and 46 and divide this sum by the number of items (4): EatR = (Q41+Q42+Q43+Q46)/4 Carry out a linear transformation to convert to a 1-100 scale: XEatR = (EatR-1)*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life. |
6 months postoperatively | |
Secondary | Eating restriction score (XEatR) at 12 months postoperatively | Eating resection scale is calcuated according to the following equation.
Add questionnaire items 41,42, 43 and 46 and divide this sum by the number of items (4): EatR = (Q41+Q42+Q43+Q46)/4 Carry out a linear transformation to convert to a 1-100 scale: XEatR = (EatR-1)*100/3 The 4 items are belong to European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ) STO22. Each item has a value among 1, 2, 3, and 4 according to the answer and the scale score has a value ranging 0 (minimum) to 100 (maximum). Higher scores mean having more symptom and worse quality of life. |
12 months postoperatively | |
Secondary | food intake | difference of food amount between discharge day and postoperative 1 month | discharge day: up to 3 weeks postoperatively,1 month postoperatively | |
Secondary | Body weight | patient's weight in kilograms | 3 months postoperatively | |
Secondary | serum albumin | g/dL | 3 months postoperatively | |
Secondary | serum protein | g/dL | 3 months postoperatively | |
Secondary | serum cholesterol | g/dL | 3 months postoperatively | |
Secondary | seum hemoglobin | g/dL | 3 months postoperatively |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04454476 -
Reversal of Preneoplastic Metaplasia in the Stomach With MEK Inhibitor
|
Phase 1 | |
Terminated |
NCT00087191 -
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
|
N/A |